Logo image
Neurobiological markers across joint profiles of subjective cognitive decline and objective cognitive function in older adults
Journal article   Open access   Peer reviewed

Neurobiological markers across joint profiles of subjective cognitive decline and objective cognitive function in older adults

Lu Wan, Chaeryon Kang, Rae Harrison, Patricio Solis-Urra, Kelsey R Sewell, Lauren E Oberlin, Shivangi Jain, Haiqing Huang, George Grove, M Ilyas Kamboh, …
Alzheimer's & dementia, Vol.22(8), e71743
2026
PMID: 42576170
pdf
Published1.36 MBDownloadView
Open Access CC BY-NC-ND V4.0

Abstract

Aged Aged, 80 and over Aging Biomarkers - blood Brain - diagnostic imaging Brain - pathology Cognition - physiology Cognitive Dysfunction - blood Cognitive Dysfunction - diagnostic imaging Cognitive Dysfunction - psychology Female Glial Fibrillary Acidic Protein - blood Humans Magnetic Resonance Imaging Male Neurofilament Proteins - blood Neuropsychological Tests tau Proteins - blood
INTRODUCTION Subjective cognitive concerns frequently diverge from objective cognitive performance in cognitively unimpaired (CU) older adults, yet the neurobiological basis of this mismatch remains unclear. METHODS In 648 participants from the Investigating Gains in Neurocognition in an Intervention Trial of Exercise (IGNITE), we defined four profiles by integrating subjective and objective cognitive status. We examined associations with plasma neurofilament light chain (NfL), phosphorylated tau 217 (p-tau217), glial fibrillary acidic protein (GFAP), a magnetic resonance imaging–based volumetric Alzheimer's disease (AD) signature reflecting atrophy, and brain-predicted age difference (brain-PAD). RESULTS Joint profiles were differentially associated with NfL (P = 0.0427) and brain-PAD (P = 0.0296). Follow-up contrasts further indicated higher NfL and lower volumetric AD signature in the concordant lower functioning profile, and higher brain-PAD in discordant profiles. p-tau217 and GFAP did not differ across profiles. DISCUSSION Joint subjective–objective cognitive profiles may capture biologically meaningful heterogeneity relevant to neurodegeneration and brain aging in older adults. TRIAL REGISTRATION ClinicalTrials.gov: NCT02875301

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

Metrics

1 Record Views
Logo image